Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn

Pediatric Research

Volumn 71, Issue 2, 2012, Pages 162-167

  Byers, Heather M ^a   Dagle, John M ^a   Klein, Jonathan M ^a   Ryckman, Kelli K ^a   McDonald, Erin L ^a   Murray, Jeffrey C ^a   Borowski, Kristi S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING HORMONE BINDING PROTEIN; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUCOCORTICOID RECEPTOR; PHOSPHODIESTERASE 5A; PHOSPHODIESTERASE V; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; ENDOTHELIAL PAS DOMAIN PROTEIN 1 GENE; ENDOTHELIUM CELL; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CARRIER PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; IOWA; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; PEDIGREE; PERSISTENT FETAL CIRCULATION SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855910548     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2011.24     Document Type: Article

References (53)

1. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105(1 Pt 1):14-20. (Pubitemid 30035712)
2. Farrow KN, Fliman P, Steinhorn RH. The diseases treated with ECMO: focus on PPHN. Semin Perinatol 2005;29:8-14. (Pubitemid 40488986)
3. John E, Roberts V, Burnard ED. Persistent pulmonary hypertension of the newborn treated with hyperventilation: clinical features and outcome. Aust Paediatr J 1988;24:357-61. (Pubitemid 19043058)
4. Clark RH, Huckaby JL, Kueser TJ, et al.; Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 2003;23:300-3. (Pubitemid 36764119)
5. Hageman JR, Adams MA, Gardner TH. Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management. Am J Dis Child 1984;138:592-5. (Pubitemid 14100988)
6. Abman SH. New developments in the pathogenesis and treatment of neonatal pulmonary hypertension. Pediatr Pulmonol Suppl 1999;18:201-4. (Pubitemid 29140354)
7. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87. (Pubitemid 43209105)
8. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5. (Pubitemid 26338730)
9. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001;107:519-23. (Pubitemid 32183186)
10. Harrison RE, Berger R, Haworth SG, et al. Transforming growth factorbeta receptor mutations and pulmonary arterial hypertension in childhood. Circulation 2005;111:435-41. (Pubitemid 40204427)
11. Sztrymf B, Yäi A, Girerd B, Humbert M. Genes and pulmonary arterial hypertension. Respiration 2007;74:123-32. (Pubitemid 46340871)
12. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 2006;164: 921-35. (Pubitemid 44729832)
13. Pearson DL, Dawling S, Walsh WF, et al. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoylphosphate synthetase function. N Engl J Med 2001;344:1832-8. (Pubitemid 32538696)
14. Villanueva ME, Zaher FM, Svinarich DM, Konduri GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 1998;44:338-43. (Pubitemid 28389988)
15. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008;122:479-85.
16. Nickel N, Kempf T, Tapken H, et al. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;178:534-41.
17. Silverman ES, Breault DT, Vallone J, et al. Corticotropin-releasing hormone deficiency increases allergen-induced airway inflammation in a mouse model of asthma. J Allergy Clin Immunol 2004;114:747-54. (Pubitemid 39330242)
18. Pavlovic J, Papagaroufalis C, Xanthou M, et al. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers 2006;22:277-91. (Pubitemid 46333635)
19. Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr 2007;151:322-4. (Pubitemid 47284148)
20. Rogers AJ, Tantisira KG, Fuhlbrigge AL, et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics 2009;10:1231-42.
21. Melnick M, Choy HA, Jaskoll T. Glucocorticoids, tumor necrosis factoralpha, and epidermal growth factor regulation of pulmonary morphogenesis: a multivariate in vitro analysis of their related actions. Dev Dyn 1996;205:365-78. (Pubitemid 26098546)
22. Sztrymf B, Coulet F, Girerd B, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008;177:1377-83. (Pubitemid 351860916)
23. Machado RD, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:Suppl 1:S32-42.
24. National Newborn Screening and Genetics Resource Center (NNSGRC). Congenital adrenal hyperplasia. In: National Newborn Screening Report-2000. Austin, TX: University of Texas, 2003:121-33.
25. International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
26. Simon DM, Mariani TJ. Role of PPARs and Retinoid X Receptors in the Regulation of Lung Maturation and Development. PPAR Res 2007;2007:91240.
27. Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995;373:427-32.
28. Garbrecht MR, Klein JM, Schmidt TJ, Snyder JM. Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system. Biol Neonate 2006;89:109-19. (Pubitemid 43256525)
29. Smith GW, Aubry JM, Dellu F, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998;20:1093-102. (Pubitemid 28293127)
30. Muglia LJ, Bae DS, Brown TT, et al. Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. Am J Respir Cell Mol Biol 1999;20:181-8. (Pubitemid 129504877)
31. Brosnan PG. The hypothalamic pituitary axis in the fetus and newborn. Semin Perinatol 2001;25:371-84. (Pubitemid 33140481)
32. Grammatopoulos D, Dai Y, Chen J, et al. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 1998;83: 2539-44. (Pubitemid 28503059)
33. Hoskote AU, Castle RA, Hoo AF, et al. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension. Pediatr Pulmonol 2008;43:224-35. (Pubitemid 351374454)
34. Bernbaum JC, Russell P, Sheridan PH, Gewitz MH, Fox WW, Peckham GJ. Long-term follow-up of newborns with persistent pulmonary hypertension. Crit Care Med 1984;12:579-83. (Pubitemid 14087409)
35. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997;337:1285-92. (Pubitemid 27461285)
36. Martins PG, Procianoy RS. Cortisol and 17-alpha-hydroxy-progesterone levels in infants with refractory hypotension born at 30 weeks of gestation or less. Braz J Med Biol Res 2007;40:577-82. (Pubitemid 46605031)
37. Quintos JB, Boney CM. Transient adrenal insufficiency in the premature newborn. Curr Opin Endocrinol Diabetes Obes 2010;17:8-12.
38. Tantivit P, Subramanian N, Garg M, Ramanathan R, deLemos RA. Low serum cortisol in term newborns with refractory hypotension. J Perinatol 1999;19:352-7.
39. Fernandez EF, Watterberg KL. Relative adrenal insufficiency in the preterm and term infant. J Perinatol 2009;29:Suppl 2:S44-9.
40. Fernandez E, Schrader R, Watterberg K. Prevalence of low cortisol values in term and near-term infants with vasopressor-resistant hypotension. J Perinatol 2005;25:114-8. (Pubitemid 40277383)
41. Kamath BD, Fashaw L, Kinsella JP. Adrenal insufficiency in newborns with congenital diaphragmatic hernia. J Pediatr 2010;156:495-7.e1.
42. Michalaki M, Margeli T, Tsekouras A, Gogos CH, Vagenakis AG, Kyriazopoulou V. Hypothalamic-pituitary-adrenal axis response to the severity of illness in non-critically ill patients: does relative corticosteroid insufficiency exist? Eur J Endocrinol 2010;162:341-7.
43. Chandrasekar I, Eis A, Konduri GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res 2008;63:67-72.
44. Ng PC, Lam CW, Lee CH, et al. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab 2002;87:4621-8. (Pubitemid 35247051)
45. da Costa DE, Nair AK, Pai MG, Al Khusaiby SM. Steroids in full term infants with respiratory failure and pulmonary hypertension due to meconium aspiration syndrome. Eur J Pediatr 2001;160:150-3. (Pubitemid 32206341)
46. Herńdez-D̈z S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 2007;120:e272-82. (Pubitemid 47219476)
47. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16. (Pubitemid 23311321)
48. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001;9:301-6. (Pubitemid 32366699)
49. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000;19:Suppl 1: S36-42.
50. Risch N, Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 1998;8:1273-88. (Pubitemid 29039099)
51. Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW. Corrected 17-alphahydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants. Ann Clin Lab Sci 2008;38:235-40.
52. Box GEP, Cox DR. An analysis of transformations. J Roy Statistical Society. 1964 (Ser B) 26:211-52.
53. Ehn NL, Cooper ME, Orr K, et al. Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth. Pediatr Res 2007;62:630-5. (Pubitemid 351339003)